Waltham Forest Anticoagulation Services

NHS Waltham Forest Clinical Commissioning GroupcontractContracts FinderRef BIP271134461SME suitableVCSE suitableclosed
View buyer

Estimated value

Awarded value

Suppliers

0

Lots

1

0 awarded

Published

21 Aug 2017

Deadline 03 Sept 2017

Description

Text to be corrected in the original notice: Place of text to be modified: II.1.4 Instead of: Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1 January 2018 - 31 December 2020, with the option to extend for up to a further two years. Annual contract value is £292,000 Read: Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1 February 2018 - 31 January 2021, with the option to extend for up to a further two years. Annual contract value is £292,000 Other additional information: Due to the level of interest in this project and the need to ensure sufficient time to identify and mobilise a provider, the start date for this contract will now be 1st February 2018.\" Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary

Scope

Reference
BIP271134461
Commercial tool
Standalone contract
Contract dates
01 Feb 2018 to 31 Jan 2021
CPV classifications
85100000
Particular suitability
Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)

Submission & procedure

Submission deadline
03 Sept 2017, 11:00 pm